bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive tests for early-stage cancer detection, will join Federal Supply System (FSS) officials today in a joint presentation. The…
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed…
Henry Schein, Inc. (Nasdaq: HSIC) is showcasing a comprehensive range of dental solutions at the 2024 Greater New York Dental Meeting (GNYDM), taking place at the Henry Schein Dental (#4215)…
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live…
UnitedHealth Group (NYSE: UNH) has announced its financial guidance in advance of its annual Investor Conference, which will take place on December 4, starting at 8:00 a.m. ET. The company…
The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform…
Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will…
Bayer continues to enhance its comprehensive radiology portfolio by advancing innovations in Artificial Intelligence (AI) and expanding its product pipeline. These advancements will be showcased at the 2024 Radiological Society…
Sickday Medical House Calls, the largest and longest-serving medical house call practice in New York City, is reshaping the way travelers experience healthcare. For nearly two decades, Sickday has been…
Teladoc Health has introduced a groundbreaking technology that combines artificial intelligence (AI) and real-time monitoring to enhance patient safety in hospitals. This innovative solution, known as Virtual Sitter, is designed…
Galderma recently announced that the full results from the Phase III OLYMPIA 1 trial, which evaluated the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis, were published…
Oxford Nanopore Technologies, a leader in advanced nanopore-based molecular sensing technology, has announced a groundbreaking collaboration with UK Biobank to create the world’s first large-scale, comprehensive epigenetic dataset. Utilizing Oxford…
